|
GPR173 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.15829592981254E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.38579999983979E-07 |
| Normal-vs-Stage2 |
4.937600E-02 |
| Normal-vs-Stage3 |
4.311700E-02 |
| Normal-vs-Stage4 |
5.102400E-01 |
| Stage1-vs-Stage2 |
3.315800E-01 |
| Stage1-vs-Stage3 |
9.915600E-01 |
| Stage1-vs-Stage4 |
8.596000E-01 |
| Stage2-vs-Stage3 |
3.766800E-01 |
| Stage2-vs-Stage4 |
4.587600E-01 |
| Stage3-vs-Stage4 |
8.353000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.8780000604911E-10 |
| Normal-vs-AfricanAmerican |
1.258250E-02 |
| Normal-vs-Asian |
9.944800E-01 |
| Caucasian-vs-AfricanAmerican |
4.096400E-01 |
| Caucasian-vs-Asian |
2.193600E-01 |
| AfricanAmerican-vs-Asian |
4.252800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.28279999955794E-07 |
| Normal-vs-Female |
1.5680999999601E-06 |
| Male-vs-Female |
2.035600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.836600E-03 |
| Normal-vs-Extreme_Weight |
4.832800E-04 |
| Normal-vs-Obese |
5.409900E-04 |
| Normal-vs-Extreme_Obese |
2.251800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.753800E-01 |
| Normal_Weight-vs-Obese |
4.777200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.287800E-01 |
| Extreme_Weight-vs-Obese |
2.043000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.895000E-01 |
| Obese-vs-Extreme_Obese |
5.562000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.952380E-01 |
| Normal-vs-Age(41-60Yrs) |
8.92730001034181E-09 |
| Normal-vs-Age(61-80Yrs) |
3.9989000000018E-05 |
| Normal-vs-Age(81-100Yrs) |
1.424360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.376800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.501400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.506400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.402240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.676000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.405000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.29250055103114E-10 |
| Normal-VS-Type2 PRCC |
1.344840E-01 |
| Normal-VS-KIRP CIMP |
1.66080038610517E-10 |
| Normal-VS-Unclassified PRCC |
2.427000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.978200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.62458935193399E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
3.414800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.61871999999619E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.044300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.78270000048298E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.622100E-03 |
| Normal-vs-N1 |
1.092450E-01 |
| Normal-vs-N2 |
3.888200E-01 |
| N0-vs-N1 |
5.277800E-01 |
| N0-vs-N2 |
8.773600E-01 |
| N1-vs-N2 |
7.351200E-01 |
|
|
